# Hyperliquid Strategies Inc: filings

PURR · Nasdaq · CIK 2078856 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/purr.md) · [Financials](/companies/purr/financials.md) · [Filings](/companies/purr/filings.md) · [Insiders](/companies/purr/insiders.md)

## Reports and events: 22 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 41, 3 10, 8-K 10, 424B3 7, 10-Q 3, 425 3, S-1 3, S-1/A 3, SCHEDULE 13G 3, CORRESP 2, EFFECT 2, S-4/A 2, SCHEDULE 13G/A 2, UPLOAD 2, 10-K 1, 8-A12B 1, 8-A12B/A 1, 8-K/A 1, ARS 1, CERT 1, DEF 14A 1, DRS 1, PRE 14A 1, S-4 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 09:13 ET | [8-K](/filings/0001193125-26-431200.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-431200 |
| 2026-10-02 | 17:02 ET | [DEF 14A](/filings/0001193125-26-412569.md) | Proxy statement, period 2026-11-04 | 0001193125-26-412569 |
| 2026-09-15 | 21:54 ET | [S-1](/filings/0001193125-26-391097.md) | Registration statement | 0001193125-26-391097 |
| 2026-09-15 | 21:39 ET | [8-K](/filings/0001193125-26-391090.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-391090 |
| 2026-09-14 | 08:56 ET | [8-K](/filings/0001193125-26-389910.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-389910 |
| 2026-09-01 | 17:00 ET | [8-K](/filings/0001193125-26-378589.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-378589 |
| 2026-08-27 | 11:45 ET | [10-K](/filings/0001193125-26-370281.md) | Annual report, period 2026-06-30 | 0001193125-26-370281 |
| 2026-08-27 | 08:32 ET | [8-K](/filings/0001193125-26-369668.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-369668 |
| 2026-07-21 | 21:39 ET | [S-1/A](/filings/0001193125-26-309340.md) | Registration statement, amended | 0001193125-26-309340 |
| 2026-06-26 | 17:03 ET | [8-K](/filings/0001193125-26-285672.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-285672 |
| 2026-06-25 | 17:22 ET | [S-1/A](/filings/0001193125-26-283059.md) | Registration statement, amended | 0001193125-26-283059 |
| 2026-06-16 | 17:18 ET | [S-1/A](/filings/0001193125-26-272886.md) | Registration statement, amended | 0001193125-26-272886 |
| 2026-05-22 | 18:04 ET | [S-1](/filings/0001193125-26-234992.md) | Registration statement | 0001193125-26-234992 |
| 2026-05-08 | 17:45 ET | [10-Q](/filings/0001193125-26-212519.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212519 |
| 2026-05-07 | 16:30 ET | [8-K](/filings/0001193125-26-212109.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-212109 |
| 2026-02-18 | 19:18 ET | [8-K/A](/filings/0001193125-26-055449.md) | 9.01 Financial statements and exhibits | 0001193125-26-055449 |
| 2026-02-11 | 11:55 ET | [10-Q](/filings/0001193125-26-045901.md) | Quarterly report, period 2025-12-31 | 0001193125-26-045901 |
| 2026-02-11 | 07:25 ET | [8-K](/filings/0001193125-26-045553.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-045553 |
| 2025-12-08 | 17:09 ET | [10-Q](/filings/0001193125-25-311400.md) | Quarterly report, period 2025-09-30 | 0001193125-25-311400 |
| 2025-12-08 | 09:27 ET | [8-K](/filings/0001193125-25-310714.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-310714 |
| 2025-12-03 | 08:10 ET | [8-K](/filings/0001493152-25-025886.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-025886 |
| 2025-10-22 | 17:14 ET | [S-1](/filings/0001493152-25-018936.md) | Registration statement | 0001493152-25-018936 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:30 ET. No prices; not investment advice.